Ascelia Pharma Future Growth
Future criteria checks 1/6
Ascelia Pharma is forecast to grow earnings and revenue by 4.4% and 59.8% per annum respectively. EPS is expected to grow by 5.7% per annum. Return on equity is forecast to be 105% in 3 years.
Key information
4.4%
Earnings growth rate
5.7%
EPS growth rate
Biotechs earnings growth | 38.9% |
Revenue growth rate | 59.8% |
Future return on equity | 105.0% |
Analyst coverage | Low |
Last updated | 13 Feb 2024 |
Recent future growth updates
Recent updates
Is Ascelia Pharma (STO:ACE) In A Good Position To Invest In Growth?
May 11Ascelia Pharma (STO:ACE) Is In A Good Position To Deliver On Growth Plans
Aug 05We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth
Jan 24We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth
Aug 23Companies Like Ascelia Pharma (STO:ACE) Are In A Position To Invest In Growth
May 19Here's What Ascelia Pharma AB (publ)'s (STO:ACE) Shareholder Ownership Structure Looks Like
Mar 07Helena Wennerström Is The Independent Director of Ascelia Pharma AB (publ) (STO:ACE) And They Just Picked Up 125% More Shares
Dec 09We Think Ascelia Pharma (STO:ACE) Can Afford To Drive Business Growth
Nov 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 33 | N/A | -51 | -51 | 2 |
12/31/2025 | N/A | -102 | -94 | -94 | 2 |
12/31/2024 | N/A | -37 | -41 | -41 | 2 |
12/31/2023 | N/A | -109 | -127 | -127 | N/A |
9/30/2023 | N/A | -152 | -140 | -140 | N/A |
6/30/2023 | N/A | -157 | -141 | -141 | N/A |
3/31/2023 | N/A | -139 | -131 | -131 | N/A |
12/31/2022 | N/A | -131 | -125 | -125 | N/A |
9/30/2022 | N/A | -113 | -129 | -129 | N/A |
6/30/2022 | N/A | -115 | -127 | -127 | N/A |
3/31/2022 | N/A | -126 | -125 | -125 | N/A |
12/31/2021 | N/A | -126 | -117 | -117 | N/A |
9/30/2021 | N/A | -127 | -112 | -112 | N/A |
6/30/2021 | N/A | -113 | -100 | -100 | N/A |
3/31/2021 | N/A | -111 | -90 | -90 | N/A |
12/31/2020 | N/A | -99 | -86 | -86 | N/A |
9/30/2020 | N/A | -90 | -75 | -75 | N/A |
6/30/2020 | N/A | -88 | -76 | -76 | N/A |
3/31/2020 | N/A | -71 | -70 | -70 | N/A |
12/31/2019 | N/A | -66 | -54 | -54 | N/A |
9/30/2019 | N/A | -46 | -47 | -47 | N/A |
6/30/2019 | N/A | -37 | -30 | -30 | N/A |
3/31/2019 | N/A | -30 | -19 | -19 | N/A |
12/31/2018 | N/A | -23 | -19 | -19 | N/A |
9/30/2018 | N/A | -22 | -17 | -17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACE is forecast to have no revenue next year.
High Growth Revenue: ACE is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACE's Return on Equity is forecast to be very high in 3 years time (105%).